← All stocks

Atea Pharmaceuticals, Inc.

AVIR No buying or selling

CIK 0001593899 #3209 in the set updated 21 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

12 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Corcoran Andrea

See Remarks

—

823,576

$3.44M

+20.0%

Sommadossi Jean-Pierre

President, CEO, and Chairman

—

767,830

$3.20M

+558.8%

BERGER FRANKLIN M

Director

—

536,097

$2.24M

−37.8%

Lucidi Bruno

Director

—

142,350

$593.81K

+71.2%

Hammond Janet MJ

Chief Development Officer

—

127,665

$532.55K

+220.5%

Polsky Bruce

Director

—

124,806

$520.63K

+90.2%

Murphy Polly A.

Director

—

121,745

$507.86K

+115.7%

Horga Maria Arantxa

Chief Medical Officer

—

96,086

$400.82K

+274.4%

DUNCAN BARBARA GAYLE

Director

—

92,350

$385.24K

+178.6%

Adams Jerome M.

Director

—

92,350

$385.24K

+178.6%

Vavricka John

Chief Commercial Officer

—

82,594

$344.54K

+283.9%

Foster Wayne

EVP, Chief Accounting Officer

—

79,329

$330.92K

+280.3%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 30 Oct 2020